Naproxen and Tofranil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Naproxen (naproxen) and Tofranil (imipramine hydrochloride). Common drug interactions include pain in extremity among females and bipolar disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Naproxen and Tofranil. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,033 Naproxen users. Check the latest studies of Naproxen.

What is Tofranil?

Tofranil has active ingredients of imipramine hydrochloride. It is often used in depression. eHealthMe is studying from 2,012 Tofranil users. Check the latest studies of Tofranil.



On Aug, 10, 2026

14 people who take Naproxen and Tofranil together, and have interactions are studied.

Naproxen and Tofranil drug interactions.

What are the common drug interactions of Naproxen and Tofranil, by gender? *:

female:

  1. Pain in extremity
  2. Anaemia (lack of blood)
  3. Blood triglycerides increased
  4. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  5. Cataract (clouding of the lens inside the eye)
  6. Epistaxis (bleed from the nose)
  7. Feeling hot
  8. Headache (pain in head)
  9. Hypertension (high blood pressure)
  10. Nasopharyngitis (inflammation of the nasopharynx)

male:

  1. Bipolar disorder (mood disorder)
  2. Chest discomfort
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Confusional state
  5. Dyspepsia (indigestion)
  6. Fatigue (feeling of tiredness)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Urinary tract obstruction

What are the common drug interactions of Naproxen and Tofranil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cardiac arrest
  2. Completed suicide (act of taking one's own life)
  3. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

20-29:

n/a

30-39:

  1. Completed suicide (act of taking one's own life)
  2. Multiple drug overdose intentional

40-49:

  1. Drug dependence
  2. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)

50-59:

  1. Bipolar disorder (mood disorder)
  2. Chest discomfort
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Confusional state
  5. Dyspepsia (indigestion)
  6. Fatigue (feeling of tiredness)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Urinary tract obstruction

60+:

  1. Blood cholesterol increased
  2. Drug ineffective
  3. Hypertension (high blood pressure)
  4. Nasopharyngitis (inflammation of the nasopharynx)
  5. Procedural pain
  6. Renal colic (renal pain)
  7. Sinusitis (inflammation of sinus)
  8. Skin discolouration (change of skin colour)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Tendonitis (a condition that causes pain and swelling of tendons)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 35.71%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 28.57%
  3. Tendon Disorder (disease of tendon): 3 people, 21.43%
  4. Quit Smoking: 3 people, 21.43%
  5. Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 21.43%
  6. High Blood Cholesterol: 3 people, 21.43%
  7. Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 3 people, 21.43%
  8. Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 7.14%
  9. Breakthrough Pain: 1 person, 7.14%
  10. Back Pain: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Naproxen and Tofranil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Naproxen and Tofranil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Naproxen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tofranil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naproxen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tofranil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naproxen and imipramine hydrochloride (the active ingredients of Naproxen and Tofranil, respectively), and Naproxen and Tofranil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: